Price tag on gene therapy for rare form of blindness: $850K … – Financial Post
Financial Post |
Price tag on gene therapy for rare form of blindness: $850K …
Financial Post FILE – In this Oct. 4, 2017, file photo, Dr. Albert Maguire, right, checks the eyes of Misa Kaabali, 8, at the Children’s Hospital of Philadelphia. Misa was 4-years-old when he received his gene therapy treatment. The first-of-its kind genetic … Spark Therapeutics Sets Price Of Blindness-Treating Gene Therapy At $850000Forbes Spark Therapeutics Announces First-of-their-kind Programs to Improve Patient Access to LUXTURNA™ (voretigene …Spark Therapeutics Inc. A US drugmaker offers to cure rare blindness for $850000CNBC |
Reuters |
Sangamo partners with Pfizer to develop gene therapy for ALS
Reuters The agency last month approved Spark Therapeutics Inc’s treatment for a rare form of blindness, marking the first approval of a gene therapy for an inherited disease. Under the terms of the deal, Sangamo will receive a $12 million upfront payment from … Sangamo, Pfizer Collaborate On Zinc Finger Protein Gene Therapy For ALSNasdaq Sangamo teams up with Pfizer to develop gene therapy to treat ALS; shares ahead 4% premarketSeeking Alpha Sangamo, Pfizer to Develop Gene Therapy for Neurodegenerative DisordersFox Business Endpoints News all 5 news articles » |
Genetic Literacy Project |
Should patients—not the FDA— have final say on risky gene therapy …
Genetic Literacy Project Working with mice, researchers have used gene therapy to restore sight to the blind, reprogram the body’s own T cells to attack cancerous tumors, prevent t. |